Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CD19+ Diffuse Large B-cell Lymphomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT02051257
What this trial is testing

Memory Enriched T Cells Following Stem Cell Transplant in Treating Patients With Recurrent B-Cell Non-Hodgkin Lymphoma

Who this might be right for
Recurrent Diffuse Large B-Cell LymphomaRecurrent Mantle Cell LymphomaRefractory Diffuse Large B-Cell Lymphoma+2 more
City of Hope Medical Center 51
Early research (Phase 1)Active Not RecruitingNCT04594642
What this trial is testing

AZD0486 in Subjects With B-Cell Non-Hodgkin Lymphoma

Who this might be right for
B-cell Non Hodgkin LymphomaDiffuse Large B Cell LymphomaHigh-grade B-cell Lymphoma+1 more
AstraZeneca 226
Very early researchLooking for participantsNCT06120166
What this trial is testing

Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r DLBCL Clinical Research

Who this might be right for
Diffuse Large B-cell Lymphoma
He Huang 18
Testing effectiveness (Phase 2)Study completedNCT00924326
What this trial is testing

CAR T Cell Receptor Immunotherapy for Patients With B-cell Lymphoma

Who this might be right for
Primary Mediastinal B-cell LymphomaDiffuse, Large B-cell LymphomaDiffuse Large B-Cell Lymphoma Transformed From Follicular Lymphoma+1 more
National Cancer Institute (NCI) 43
Testing effectiveness (Phase 2)Looking for participantsNCT03676504
What this trial is testing

Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CAR

Who this might be right for
Acute Lymphoblastic Leukemia, AdultAcute Lymphoblastic Leukemia, PediatricChronic Lymphocytic Leukemia+3 more
University Hospital Heidelberg 68
Very early researchNot Yet RecruitingNCT07168291
What this trial is testing

Novel Bispecific AbTCR (Anti-CD19/CD22)-T Cells in Relapsed or Refractory B-cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma (DLBCL)Follicular Lymphoma ( FL)Burkitt Lymphoma
First Affiliated Hospital Xi'an Jiaotong University 3
Early research (Phase 1)Not Yet RecruitingNCT07725406
What this trial is testing

Low-Dose TBI Plus CAR T-Cell Therapy for Relapsed/Refractory DLBCL and Multiple Myeloma

Who this might be right for
Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)Relapsed or Refractory Multiple Myeloma (MM)
Weill Medical College of Cornell University 32
Early research (Phase 1)Study completedNCT04450069
What this trial is testing

CLBR001 and SWI019 in Patients With Relapsed / Refractory B-cell Malignancies

Who this might be right for
Relapsed/Refractory B-cell LymphomasDiffuse Large B Cell Lymphoma (DLBCL)Follicular Lymphoma (FL)+9 more
Calibr, a division of Scripps Research 18
Testing effectiveness (Phase 2)Looking for participantsNCT04186520
What this trial is testing

CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies

Who this might be right for
Non Hodgkin Lymphoma (NHL)Mantle Cell Lymphoma (MCL)Chronic Lymphocytic Leukemia (CLL)+5 more
Medical College of Wisconsin 100
Testing effectiveness (Phase 2)Looking for participantsNCT07288879
What this trial is testing

DALY II Japan/MB-CART2019.1 for DLBCL

Who this might be right for
DLBCL - Diffuse Large B Cell LymphomaCAR T Cell Therapy
Miltenyi Biomedicine GmbH 31
Early research (Phase 1)WithdrawnNCT04052061
What this trial is testing

QUILT-3.061: CD19 t-haNK in Subjects With Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B Cell LymphomaLarge-cell LymphomaLymphoma, B-Cell+1 more
ImmunityBio, Inc.
Not applicableStudy completedNCT05784415
What this trial is testing

Observational Study of People Living With HIV Treated With CD19-directed CAR T Cell

Who this might be right for
LeukemiaLeukemia, LymphoblasticLymphoma, Large B-Cell, Diffuse+7 more
AIDS Malignancy Consortium 30
Testing effectiveness (Phase 2)UnknownNCT02652910
What this trial is testing

Memory-enriched CAR-T Cells Immunotherapy for B Cell Lymphoma

Who this might be right for
Recurrent Adult Diffuse Large Cell LymphomaRecurrent Follicular LymphomaRecurrent Mantle Cell Lymphoma+6 more
Xinqiao Hospital of Chongqing 20
Large-scale testing (Phase 3)Active Not RecruitingNCT04824092
What this trial is testing

Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients

Who this might be right for
Diffuse Large B-cell Lymphoma
Incyte Corporation 899
Early research (Phase 1)Looking for participantsNCT05432635
What this trial is testing

Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) Following Stem Cell Transplantation for the Treatment of Intermediate or High Grade B-cell Non-Hodgkin Lymphoma

Who this might be right for
B-Cell Non-Hodgkin LymphomaDiffuse Large B-Cell LymphomaMantle Cell Lymphoma+5 more
City of Hope Medical Center 15
Early research (Phase 1)Looking for participantsNCT06047197
What this trial is testing

Phase I Clinical Trial of RC19D2 Cell Injection in the Treatment of Diffuse Large B-cell Lymphoma

Who this might be right for
Recurrent Diffuse Large B-Cell LymphomaRefractory Diffuse Large B-cell Lymphoma
Beijing Yongtai Ruike Biotechnology Company Ltd 25
Testing effectiveness (Phase 2)UnknownNCT02737085
What this trial is testing

The Sequential Therapy of CD19-targeted and CD20-targeted CAR-T Cell Therapy for Diffuse Large B Cell Lymphoma(DLBCL)

Who this might be right for
Lymphoma, Large B-Cell, Diffuse
Southwest Hospital, China 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT05222555
What this trial is testing

Safety and Pharmacokinetics Study of a Modified Tafasitamab IV Dosing Regimen Combined With Lenalidomide in R-R DLBCL Patients

Who this might be right for
Diffuse Large B Cell Lymphoma
Incyte Corporation 53
Early research (Phase 1)Enrolling By InvitationNCT06827782
What this trial is testing

Cord Blood-derived CAR-NK Cells Targeting CD19 for Refractory/Relapsed Central Nervous System Lymphoma

Who this might be right for
Refractory/Recurrent Central Nervous System Lymphoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 42
Early research (Phase 1)Looking for participantsNCT06026319
What this trial is testing

CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma

Who this might be right for
Non-hodgkin LymphomaRelapsed Non-Hodgkin LymphomaRefractory Non-Hodgkin Lymphoma+7 more
Marcela V. Maus, M.D.,Ph.D. 24
Next Page